Acticor Biotech SAS (EPA:ALACT)
0.2500
0.00 (0.00%)
Inactive · Last trade price
on Dec 9, 2024
Acticor Biotech SAS Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Cash & Equivalents | 4.82 | 3.89 | 6.6 | 11.35 | 7.59 | 12.88 | Upgrade
|
Cash & Short-Term Investments | 4.82 | 3.89 | 6.6 | 11.35 | 7.59 | 12.88 | Upgrade
|
Cash Growth | -39.46% | -41.13% | -41.85% | 49.57% | -41.11% | 26.43% | Upgrade
|
Other Receivables | 4.77 | 4.38 | 4.84 | 4.28 | 1.93 | 1.38 | Upgrade
|
Receivables | 4.77 | 4.38 | 4.84 | 4.28 | 1.93 | 1.38 | Upgrade
|
Prepaid Expenses | 0.06 | 0.99 | 0.3 | 1.24 | 0.6 | 0.19 | Upgrade
|
Total Current Assets | 9.65 | 9.26 | 11.74 | 16.87 | 10.12 | 14.46 | Upgrade
|
Property, Plant & Equipment | 0.02 | 0.02 | 0.01 | 0.1 | 0.18 | 0.23 | Upgrade
|
Other Intangible Assets | 0.17 | - | 0.71 | 0.71 | 0.71 | 0.71 | Upgrade
|
Other Long-Term Assets | 0.39 | 0.44 | 0.48 | 0.2 | 0 | - | Upgrade
|
Total Assets | 10.22 | 9.72 | 12.94 | 17.88 | 11.02 | 15.4 | Upgrade
|
Accounts Payable | 7.36 | 7.86 | 5.14 | 3.03 | 2.72 | 1.62 | Upgrade
|
Accrued Expenses | 0.91 | 0.82 | 0.57 | 0.47 | 0.24 | 0.18 | Upgrade
|
Short-Term Debt | - | - | - | - | - | 0 | Upgrade
|
Current Portion of Long-Term Debt | 3.09 | 0.66 | 0.8 | 0.46 | 0.1 | 0.05 | Upgrade
|
Current Portion of Leases | - | - | - | 0.05 | 0.06 | 0.06 | Upgrade
|
Current Income Taxes Payable | - | 0.05 | 0.05 | 0.06 | - | 0.01 | Upgrade
|
Current Unearned Revenue | - | - | 0.14 | - | 3.25 | 3.25 | Upgrade
|
Other Current Liabilities | - | - | - | 0 | 0.01 | 0 | Upgrade
|
Total Current Liabilities | 11.36 | 9.4 | 6.7 | 4.06 | 6.38 | 5.16 | Upgrade
|
Long-Term Debt | 4.15 | 5.53 | 8.43 | 2.2 | 2.35 | 0.92 | Upgrade
|
Long-Term Leases | - | - | - | - | 0.05 | 0.11 | Upgrade
|
Other Long-Term Liabilities | - | 0 | - | 0.55 | 0.43 | 0.18 | Upgrade
|
Total Liabilities | 15.51 | 15.03 | 15.19 | 6.86 | 9.3 | 6.37 | Upgrade
|
Common Stock | 0.79 | 0.66 | 0.53 | 0.53 | 0.32 | 0.32 | Upgrade
|
Additional Paid-In Capital | 45.35 | 37.39 | 23.33 | 23.32 | 11.64 | 27.4 | Upgrade
|
Retained Earnings | -51.43 | -43.33 | -26.09 | -12.8 | -10.2 | -19.29 | Upgrade
|
Comprehensive Income & Other | -0 | -0.03 | -0.01 | -0.03 | -0.04 | 0.61 | Upgrade
|
Shareholders' Equity | -5.29 | -5.31 | -2.24 | 11.02 | 1.72 | 9.03 | Upgrade
|
Total Liabilities & Equity | 10.22 | 9.72 | 12.94 | 17.88 | 11.02 | 15.4 | Upgrade
|
Total Debt | 7.25 | 6.19 | 9.23 | 2.71 | 2.56 | 1.14 | Upgrade
|
Net Cash (Debt) | -2.43 | -2.3 | -2.63 | 8.64 | 5.03 | 11.75 | Upgrade
|
Net Cash Growth | - | - | - | 71.96% | -57.22% | 30.65% | Upgrade
|
Net Cash Per Share | -0.17 | -0.19 | -0.25 | 1.11 | 0.79 | 2.24 | Upgrade
|
Filing Date Shares Outstanding | 15.76 | 13.12 | 10.51 | 10.55 | 6.36 | 5.24 | Upgrade
|
Total Common Shares Outstanding | 15.76 | 13.12 | 10.51 | 10.55 | 6.36 | 5.24 | Upgrade
|
Working Capital | -1.71 | -0.14 | 5.04 | 12.82 | 3.74 | 9.29 | Upgrade
|
Book Value Per Share | -0.34 | -0.40 | -0.21 | 1.04 | 0.27 | 1.72 | Upgrade
|
Tangible Book Value | -5.46 | -5.31 | -2.96 | 10.31 | 1 | 8.32 | Upgrade
|
Tangible Book Value Per Share | -0.35 | -0.40 | -0.28 | 0.98 | 0.16 | 1.59 | Upgrade
|
Machinery | - | 0.08 | 0.09 | 0.17 | 0.17 | 0.08 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.